custom image

Joint meeting with: The Microbiome: From Mother to Child

Harnessing the Microbiome for Disease Prevention and Therapy

January 18-20, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Our understanding of the microbiome is advancing rapidly, and continues to productively move through the discovery phase, with numerous correlations being established between specific commensal microbes or microbiota compositions and a wide range of diseases that includes infections, inflammatory conditions, metabolic disease, autoimmunity and neurologic syndromes. The initial discovery of these potentially important correlations has led many laboratories around the world to probe the molecular mechanisms that form the causal link between specific commensal microbes and disease development, progression and resolution. Although there have been great advances, culturing many of the prevalent and metabolically active obligate anaerobic commensals remains a challenge. Exciting advances, however, are emerging from laboratories developing tools to genetically manipulate key commensal organisms, facilitating experimental studies that are identifying the small, bioactive molecules they produce, some of which have therapeutic potential. Studies of the impact of bacteriophage on the microbiota also suggest that they may have therapeutic potential. This Keystone conference will focus on recent advances that demonstrate, at the cellular and molecular level, the impact of the microbiota and its products on disease susceptibility/resistance, with an emphasis on microbial and host metabolism, inter-microbial interactions and the amelioration of diseases.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 7, 2021
Financial Aid Application: Passed

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk

#VKSMicrobiomeTherapy21



Program Details



Speaking at this eSymposia


Emily P. Balskus

Harvard University, USA


Paul L. Bollyky

Stanford University, USA


Laurie E. Comstock

Brigham and Women's Hospital/Harvard Medical School, USA


Mohamed S. Donia

Princeton University, USA


Michael A. Fischbach

Stanford University, USA



Wendy S. Garrett

Harvard School of Public Health, USA


Andrew L. Goodman

Yale School of Medicine, USA


Jeffrey I. Gordon

Washington University School of Medicine, USA


Chun-Jun Guo

Weill Cornell Medicine, USA


Colin Hill

University College Cork, Ireland


Kenya Honda

Keio University School of Medicine, Japan


Lora V. Hooper

University of Texas Southwestern Medical Center, USA


Ivaylo I. Ivanov

Columbia University, USA


Bana Jabri

University of Chicago, USA


Denise M. Monack

Stanford University, USA


Kiran Patil

European Molecular Biology Laboratory, Germany


Manuela Raffatellu

University of California, San Diego, USA


Seth Rakoff-Nahoum

Boston Children's Hospital, USA


Cynthia L. Sears

Johns Hopkins University School of Medicine, USA


Kimberley Seed

University of California, Berkeley, USA


Melody Smith

Memorial Sloan Kettering Cancer Center, USA


Bärbel Stecher

Ludwig-Maximilians-Universität München, Germany


Alan Walker

University of Aberdeen, Scotland


Ramnik Xavier

Massachusetts General Hospital, USA


Laurence Zitvogel

Institut Gustave Roussy, France




Sponsors


sponsor-carousel-astraz.png

sponsor-carousel-cell-research.png

Sponsor-carousel-novo-norodisk.png




Additional Support



sponsor-carousel-adipogen.png

sponsor-carousel-anaerobe-systems.png

sponsor-carousel-bmgf.png

sponsor-carousel-DCVC-bio.png

sponsor-carousel-NIAID.png

Funding for this conference was made possible (in part) by Grant No. 1R13AI154725-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

sponsor-carousel-scientist.png



#ScienceMustGoOn


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.







The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image






Donate to Keystone Symposia


custom image